Kura Oncology (KURA) Capital Expenditures (2014 - 2026)
Kura Oncology (KURA) reported Capital Expenditures of $128000.0 for Q1 2026, down 56.16% year-over-year from $292000.0 in Q1 2025, and down 97.22% quarter-over-quarter from $4.6 million in Q4 2025.
Kura Oncology (KURA) Capital Expenditures (2014 - 2026) Analysis & Trends
Kura Oncology (KURA) has 9 years of Capital Expenditures data on file, last reported at $128000.0 in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $128000.0, down 56.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.5 million (up 852.06% YoY), and the FY2025 annual result was $6.6 million, up 1306.36% from the prior year.
- Capital Expenditures fell to $128000.0 in Q1 2026 per KURA's latest filing, from $4.6 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $4.6 million in Q4 2025 and troughed at $12000.0 in Q4 2022.
- A 5-year average of $502000.0 and a median of $112000.0 in 2023 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2023 and 2025: Capital Expenditures sank 94.75% in 2023, then soared 9012.5% in 2025.
- A 5-year view of Capital Expenditures shows it stood at $12000.0 in 2022, then soared by 33.33% to $16000.0 in 2023, then jumped by 2225.0% to $372000.0 in 2024, then jumped by 1139.52% to $4.6 million in 2025, then tumbled by 97.22% to $128000.0 in 2026.
- Business Quant data shows KURA's Capital Expenditures at $128000.0 in Q1 2026, $4.6 million in Q4 2025, and $277000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Kura Oncology | 883.44 Mn | 883.44 Mn | 18.00 Mn | 128,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 128,000.00 |
| Mar 31, 2026 | 128,000.00 |
| Dec 31, 2025 | 4.61 Mn |
| Dec 31, 2025 | 4.61 Mn |
| Sep 30, 2025 | 277,000.00 |
| Sep 30, 2025 | 277,000.00 |
| Jun 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 292,000.00 |
| Mar 31, 2025 | 292,000.00 |
| Dec 31, 2024 | 372,000.00 |
| Dec 31, 2024 | 372,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | 20,000.00 |
| Sep 30, 2023 | 20,000.00 |